SydPath Supports NSW COVID-19 Outbreak with Genetic Signatures’ Testing Technology
Channel 9 interviews our customer SydPath, taking a look at their increased testing capabilities in response to the COVID-19 outbreak in NSW, implementing our high-throughput testing technology for respiratory infection
Read MoreJohn Melki speaking at ASX Small and Mid-Cap Conference
Genetic Signatures’ CEO- Dr. John Melki speaking at ASX Small and Mid-Cap Conference held in Sydney Australia September 2018
Read More